BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10786494)

  • 1. Results of a national epidemiological investigation of HCV infection in dialysis patients.
    Lombardi M; Cerrai T; Geatti S; Negroni S; Pertusini L; Pegoraro M; Di Lullo G
    EDTNA ERCA J; 1999; 25(3):38-42. PubMed ID: 10786494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a national epidemiological investigation on HCV infection among dialysis patients. (Survey by the Italian Branch of EDTNA/ERCA).
    Lombardi M; Cerrai T; Geatti S; Negroni S; Pertusini L; Pegoraro M; Di Lullo G
    J Nephrol; 1999; 12(5):322-7. PubMed ID: 10630697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National surveillance of dialysis-associated diseases in the United States, 2002.
    Finelli L; Miller JT; Tokars JI; Alter MJ; Arduino MJ
    Semin Dial; 2005; 18(1):52-61. PubMed ID: 15663766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal precautions and dedicated machines as cheap and effective measures to control HCV spread.
    Cerrai T; Michelassi S; Ierpi C; Toti G; Zignego AL; Lombardi M
    EDTNA ERCA J; 1998; 24(2):43-5, 48. PubMed ID: 10392066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C infection in dialysis patients in Israel.
    Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U
    Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodialysis of patients with HCV infection: isolation has a definite role.
    Agarwal SK
    Nephron Clin Pract; 2011; 117(4):c328-32. PubMed ID: 21051906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 1990s perspective of hepatitis C, human immunodeficiency virus, and tuberculosis infections in dialysis patients.
    Murthy BV; Pereira BJ
    Semin Nephrol; 1997 Jul; 17(4):346-63. PubMed ID: 9241719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of isolation measures on the incidence and prevalence of hepatitis C virus infection in hemodialysis.
    Gallego E; López A; Pérez J; Llamas F; Lorenzo I; López E; Illescas ML; Andrés E; Olivas E; Gómez-Roldan C
    Nephron Clin Pract; 2006; 104(1):c1-6. PubMed ID: 16685138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of hepatitis C and risk factors in haemodialysis patients in Guilan, Islamic Republic of Iran.
    Amiri ZM; Shakib AJ; Toorchi M
    East Mediterr Health J; 2005 May; 11(3):372-6. PubMed ID: 16602456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods used to reduce the prevalence of hepatitis C in a dialysis unit.
    Hussein MM; Mooij JM
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):909-13. PubMed ID: 20814130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis and transfusions.
    Donnelly K
    Nephrol Nurs J; 2000 Oct; 27(5):538-9. PubMed ID: 16649331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of hepatitis C virus among long-term dialysis patients: a 9-year study in an Italian region.
    Di Napoli A; Pezzotti P; Di Lallo D; Petrosillo N; Trivelloni C; Di Giulio S;
    Am J Kidney Dis; 2006 Oct; 48(4):629-37. PubMed ID: 16997059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infections in dialysis patients.
    Arduino MJ; Lucero C; Patel P
    Nephrol News Issues; 2008 Feb; 22(2):48-50, 53, 55-7 passim. PubMed ID: 18326462
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevalence and incidence of hepatitis C seroconversion in patients on hemodialysis].
    Resić H; Sahović V; Mesić E; Leto E
    Acta Med Croatica; 2003; 57(1):39-42. PubMed ID: 12876861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of viral transmission in HD units: the value of isolation.
    Karkar A; Abdelrahman M; Ghacha R; Malik TQ
    Saudi J Kidney Dis Transpl; 2006 Jun; 17(2):183-8. PubMed ID: 16903625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of hepatitis B virus and hepatitis C virus transmission in hemodialysis centers: review of current international recommendations.
    Elamin S; Abu-Aisha H
    Arab J Nephrol Transplant; 2011 Jan; 4(1):35-47. PubMed ID: 21469594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis C virus infection in hemodialysis].
    Simon N
    Pathol Biol (Paris); 1995 Oct; 43(8):735-40. PubMed ID: 8745596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus infection in hemodialysis patients in Sudan: two centers' report.
    El-Amin HH; Osman EM; Mekki MO; Abdelraheem MB; Ismail MO; Yousif ME; Abass AM; El-haj HS; Ammar HK
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):101-6. PubMed ID: 17237901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B and C in dialysis units in Iran: changing the epidemiology.
    Alavian SM; Bagheri-Lankarani K; Mahdavi-Mazdeh M; Nourozi S
    Hemodial Int; 2008 Jul; 12(3):378-82. PubMed ID: 18638096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.